Abbott Receives Approval For Xience Prime Everolimus Eluting Stent In Japan RTT News (RTTNews) - Abbott (ABT: News ) on Monday said it has received approval from the Japanese Ministry of Health, Labor and Welfare for the next-generation Xience Prime Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent ... |
